Our strategy

Research and art: Driving excellence 

We create world-class clusters of excellence and bring talent together.
Research equipment on a colorful background, image by Aleksi Poutanen

Our long-term purpose: 

We excel and make breakthroughs in and across science, art, technology and business.

Our current focus of development: 

Driving excellence. We create world-class clusters of excellence and bring talent together.

The planned actions: 

We cultivate excellence in our strongest areas of research and art, both existing and emerging.

We develop and support selected physical and digital infrastructures.

We collaborate to amplify our impact in a changing global landscape.
 

Our current key research areas

Our strength is excellence and increasing impact on our chosen key areas in research, art and education and a unique combination of collaborating disciplines.

Black and blue illustration of quantum world

Research & Art

Our research focuses on seven key areas combining four core competences in the fields of digitalisation, materials, arts and design, and business together with three grand challenges related to energy, living environments, and health.

News related to research and art

Person in dark suit presenting ELLIS Institute Finland slide with colourful icons in a lecture room
Cooperation, Press releases, Research & Art Published:

ELLIS Institute Finland is launching machine learning fundamentals out of the lab

Research moonshots, foundation models for healthcare, and AI for RDI
Research & Art Published:

ACRIS service restored

The ACRIS research information management system is now open following the planned service break on 13–20 April 2026.
Design Methods class smiling faces during group work. Photo: Ayse Pekdiker
Research & Art Published:

Science must have a voice in society – but how?

Trust in science has fallen in Finland by almost ten percentage points in two years
The Proteins.1 team smiling at the camera. 3 men wearing dark shirts smiling at the camera
Research & Art Published:

Meet our startup: Proteins.1 aims for a breakthrough in early disease detection

Biotechnology startup Proteins.1 is developing a technology that could enable the detection of diseases such as cancer months, or even years, earlier than is currently possible. The key lies in identifying individual proteins from a blood sample.
  • Updated:
  • Published:
Share
URL copied!